Close Menu

In a paper published online in advance in Nature this week, investigators at the Wellcome Trust Genome Campus and elsewhere report their creation of a "high-throughput gene-targeting pipeline for the generation of reporter-tagged, conditional alleles," with which to interrogate mouse gene functions. To date, the team has produced more than 12,000 vectors and 9,000 conditional, targeted alleles in "highly germline-competent C57BL/6N embryonic stem cells," it writes.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Bloomberg reports AstraZeneca may conduct another study of its candidate SARS-CoV-2 vaccine after dosing error.

Moderna is applying for an Emergency Use Authorization for its coronavirus vaccine, according to the New York Times.

The National Health Service is to conduct a trial of Grail's blood-based screening test for cancer.

In PLOS this week: somatic mutation patterns of glioblastomas among Lebanese patients, phenome-wide study using UK Biobank data, and more.